Best in Biotech 21 Mar 2023
5 advancements in Down syndrome research over the past year
…studies have shown that people with Down syndrome have a hyperactivated CB1 cannabinoid receptor, the drug candidate is based on the modulation of the receptor with specific inhibitors which has…
